{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:33Z","timestamp":1794013413933,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000740","name":"University of St Andrews","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajog.2026.04.037","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:01:51Z","timestamp":1777417311000},"page":"800-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neonatal and obstetric outcomes following periconceptional exposure to glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"235","author":[{"given":"Jolie","family":"Hakim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-2155","authenticated-orcid":false,"given":"Javier Ananda","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.04.037_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/2327-6924.12510","article-title":"Obesity: risk factors, complications, and strategies for sustainable long-term weight management","volume":"29","author":"Fruh","year":"2017","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.ajog.2026.04.037_bib5","article-title":"Impact of obesity on infertility in women","author":"Da\u011f","year":"2015","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"10.1016\/j.ajog.2026.04.037_bib6","article-title":"Obesity prevalence and its impact on maternal and neonatal outcomes in pregnant women: a systematic review","volume":"16","author":"Almutairi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajog.2026.04.037_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-12-792","article-title":"Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis","author":"Wahabi","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajog.2026.04.037_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1193271","article-title":"Management of type 2 diabetes in pregnancy: a narrative review","volume":"14","author":"Raets","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2026.04.037_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","author":"Moiz","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ajog.2026.04.037_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084334","article-title":"The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome","author":"Bednarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2026.04.037_bib11","article-title":"Weight loss efficiency and safety of tirzepatide: a systematic review","volume":"18","author":"Lin","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2026.04.037_bib12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00404-024-07849-9","article-title":"Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review. Review","volume":"311","author":"Price","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2026.04.037_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MED.0000000000000835","article-title":"Glucagon-like peptide-1 receptor agonists and safety in the preconception period","volume":"30","author":"Minis","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ajog.2026.04.037_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-023-01500-5","article-title":"Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. Review","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ajog.2026.04.037_bib18","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.04.037_bib19","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. https:\/\/synthesismanual.jbi.global. Accessed December 15, 2025.","DOI":"10.46658\/JBIMES-24-01"},{"key":"10.1016\/j.ajog.2026.04.037_bib20","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk: JBI; 2020. https:\/\/synthesismanual.jbi.global. Accessed December 16, 2025.","DOI":"10.46658\/JBIRM-17-06"},{"key":"10.1016\/j.ajog.2026.04.037_bib21","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.ajog.2026.04.037_bib22","series-title":"Systematic reviews of textual evidence: narrative, expert opinion or policy","author":"Pearson","year":"2024"},{"key":"10.1016\/j.ajog.2026.04.037_bib23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in EpidemiologyA proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2026.04.037_bib24","doi-asserted-by":"crossref","first-page":"116.e1","DOI":"10.1016\/j.ajog.2025.01.019","article-title":"Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes","volume":"233","author":"Imbroane","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.04.037_bib25","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","volume":"334","author":"Maya","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2026.04.037_bib26","article-title":"Gestational weight gain and hypertensive disorders of pregnancy with prepregnancy and early pregnancy glucagon-like Peptide-1 receptor agonist exposure","author":"Pondugula","year":"2025","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.04.037_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2026.04.037_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2025.03.013","article-title":"Efficacy and safety of glucagon-like Peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes","volume":"246","author":"Hanif","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajog.2026.04.037_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70211","article-title":"Prescription drugs in pregnancy and congenital malformations: a population-based safety screening study","volume":"34","author":"Broe","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2026.04.037_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajog.2026.04.037_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70021","article-title":"Pregnancy outcomes after semaglutide exposure","volume":"136","author":"Kolding","year":"2025","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ajog.2026.04.037_bib32","article-title":"Glucagon-Like Peptide-1 receptor agonists among pregnancies with pregestational diabetes and its relationship with congenital malformations; early access","author":"Lewin","year":"2025","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2026.04.037_bib33","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1111\/dom.16437","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: safety data from regulatory clinical trials","volume":"27","author":"Parker","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2026.04.037_bib34","article-title":"Exposure to high-dose liraglutide in a pregnant woman with obesity","volume":"2","author":"Abushanab","year":"2025","journal-title":"O G Open"},{"key":"10.1016\/j.ajog.2026.04.037_bib35","first-page":"5","article-title":"A case report of a pregnant woman with type 2 diabetes mellitus using dulaglutide during the first trimester of pregnancy","volume":"15","author":"Alghamdi","year":"2023","journal-title":"Cureus J Med Sci"},{"key":"10.1016\/j.ajog.2026.04.037_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00592-022-01954-4","article-title":"A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus","volume":"60","author":"Burlina","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajog.2026.04.037_bib37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/0118715303252109231023115112","article-title":"Case series: exposure to glucagon-like Peptide-1 receptor agonist in the first trimester of pregnancy in two siblings","volume":"24","author":"Dogan","year":"2024","journal-title":"Endocr Metab Immune Disord-Drug Targets"},{"key":"10.1016\/j.ajog.2026.04.037_bib38","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1111\/dme.12726","article-title":"Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with Type 2 diabetes","volume":"32","author":"Greco","year":"2015","journal-title":"Diabetic Med"},{"key":"10.1016\/j.ajog.2026.04.037_bib39","first-page":"70","article-title":"Pregnancy outcome and liraglutide levels in serum and umbilical vein blood of a woman with type 2 diabetes. A case report","volume":"27","author":"Ivanisevic","year":"2018","journal-title":"Gynaecol Perinatol"},{"key":"10.1016\/j.ajog.2026.04.037_bib40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00592-024-02331-z","article-title":"Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. Editorial material","volume":"61","author":"Molteni","year":"2024","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajog.2026.04.037_bib41","article-title":"Pregnancy outcomes following first trimester exposure to semaglutide. ; early Access","volume":"4","author":"Morton","year":"2025","journal-title":"Obstet Med"},{"key":"10.1016\/j.ajog.2026.04.037_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijgo.15092","article-title":"Semaglutide and pregnancy. Editorial Material","volume":"163","author":"Skov","year":"2023","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2026.04.037_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/TEN.0b013e3181a5875e","article-title":"Case report exenatide use during pregnancy","volume":"19","author":"Williams","year":"2009","journal-title":"Endocrinologist"},{"key":"10.1016\/j.ajog.2026.04.037_bib44","doi-asserted-by":"crossref","DOI":"10.53388\/CRC2024013","article-title":"Normal pregnancy outcome after first-trimester exposure to semaglutide in an overweight woman: a case report","author":"Zhu","year":"2024","journal-title":"Clin Res Commun"},{"key":"10.1016\/j.ajog.2026.04.037_bib45","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bcp.16354","article-title":"The safety profile of usage of glucagon-like peptide-1 receptor agonists in pregnancy: a pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System","volume":"91","author":"Zhou","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2026.04.037_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2025.103046","article-title":"Evaluation of GLP-1 receptor agonists in obstetrics and perinatal outcomes: a systematic review and meta-analysis","volume":"54","author":"Armstrong","year":"2025","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2026.04.037_bib47","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2014.09.031","article-title":"Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study","volume":"212","author":"Bateman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.04.037_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2022.03.003","article-title":"Maternal chronic disease and congenital anomalies of the kidney and urinary tract in offspring: a Japanese cohort study","volume":"80","author":"Nishiyama","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"Suppl_3","key":"10.1016\/j.ajog.2026.04.037_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/circ.152.suppl_3.4371548","article-title":"Abstract 4371548: GLP-1 receptor agonists use in pregnant women reduce adverse maternal and fetal outcomes: a meta-analysis","volume":"152","author":"Kodali","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2026.04.037_bib50","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2013.6295","article-title":"Maternal obesity and risk of preterm delivery","volume":"309","author":"Cnattingius","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2026.04.037_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.earlhumdev.2013.09.014","article-title":"Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns?","volume":"89","author":"van der Burg","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2026.04.037_bib52","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40262-018-0668-z","article-title":"Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist","volume":"57","author":"Hall","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2026.04.037_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1467-789X.2007.00397.x","article-title":"Maternal obesity and risk of cesarean delivery: a meta-analysis","volume":"8","author":"Chu","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajog.2026.04.037_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067946","article-title":"Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"377","author":"Ye","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.04.037_bib55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4239\/wjd.v6.i5.734","article-title":"What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes?","volume":"6","author":"Mitanchez","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ajog.2026.04.037_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.siny.2009.01.003","article-title":"Neonatal glucose metabolism in offspring of mothers with varying degrees of hyperglycemia during pregnancy","volume":"14","author":"Persson","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.04.037_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4274\/Jcrpe.1135","article-title":"Micropenis: etiology, diagnosis and treatment approaches","volume":"5","author":"Hatipo\u011flu","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.ajog.2026.04.037_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5812\/asjsm.34871","article-title":"Angular deformities of the lower limb in children","volume":"1","author":"Espandar","year":"2010","journal-title":"Asian J Sports Med"},{"key":"10.1016\/j.ajog.2026.04.037_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21037\/tp.2017.10.06","article-title":"Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes","volume":"6","author":"Sharma","year":"2017","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.ajog.2026.04.037_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review. Review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.04.037_bib61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1191\/0960327103ht402oa","article-title":"Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4)","volume":"22","author":"Hiles","year":"2003","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ajog.2026.04.037_bib62","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2026.04.037_bib63","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajog.2017.05.040","article-title":"Gestational weight gain","volume":"217","author":"Kominiarek","year":"2017","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782600222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782600222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:29:21Z","timestamp":1789673361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293782600222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S000293782600222X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.04.037","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal and obstetric outcomes following periconceptional exposure to glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}